Zogenix, Inc. To Present At Two Upcoming Conferences
Published: Jun 17, 2014
SAN DIEGO, June 16, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced that Ann Rhoads, Chief Financial Officer, will be presenting at two upcoming institutional investor conferences.
Help employers find you! Check out all the jobs and post your resume.